ALS under takeover threat

The main factor in the latest loss was the $314 million write-down of asset values in the wake of the downturn in the ...

A matter of days after being hit with a raft of 'sell' calls following disappointing annual results, laboratory testing outfit ALS is facing a potential change of control, seeking a suspension to trading in its shares.